Advertisement

Anesthesia for Pregnant Patient with Coagulation Disorders

  • Semra Karaman
  • Zeynep Cagiran
Chapter

Abstract

Obstetric coagulation disorders are one of the important contributing risk factors for maternal mortality and morbidity. Changes in coagulation affect the course of pregnancy, the mode of delivery, and subsequently approach to anesthesia type. In this chapter the physiological changes of coagulation in pregnancy, the common inherited and non-inherited hemostatic disorders that occur in pregnancy, and a focus on their implications for neuraxial anesthesia are discussed.

Keywords

Coagulation disorders Congenital coagulopathies Acquired coagulopathies Pregnancy Anesthesia implications 

References

  1. 1.
    Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004;114:409–14.CrossRefGoogle Scholar
  2. 2.
    James AH. Pregnancy and thrombotic risk. Crit Care Med. 2010;38:57–63.CrossRefGoogle Scholar
  3. 3.
    Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol. 2009;114:1326–31.CrossRefGoogle Scholar
  4. 4.
    Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Investig. 1981;12:141–54.CrossRefGoogle Scholar
  5. 5.
    Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52:176–82.PubMedGoogle Scholar
  6. 6.
    Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;119:185–8.CrossRefGoogle Scholar
  7. 7.
    Dalaker K. Clotting factor VII during pregnancy, delivery and puerperium. Br J Obstet Gynaecol. 1986;93:17–21.CrossRefGoogle Scholar
  8. 8.
    McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis and management. Blood Rev. 2003;17:7–14.CrossRefGoogle Scholar
  9. 9.
    Tanaka M, Balki M, McLeod A, Carvalho JC. Regional anesthesia and non-preeclamptic thrombocytopenia: time to re-think the safe platelet count. Rev Bras Anestesiol. 2009;59:142–53.CrossRefGoogle Scholar
  10. 10.
    Kam PC, Thompson SA, Liew AC. Thrombocytopenia in the parturient. Anaesthesia. 2004;59:255–64.CrossRefGoogle Scholar
  11. 11.
    Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003;102:887–95.CrossRefGoogle Scholar
  12. 12.
    Webert KE, Mittal R, Sigouin C, Heddle NM, Kelton JG. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003;102:4306–11.CrossRefGoogle Scholar
  13. 13.
    Bussel JB, Pham LC. Intravenous treatment with gamma globulin in adults with immune thrombocytopenic purpura: review of the literature. Vox Sang. 1987;52:206–11.CrossRefGoogle Scholar
  14. 14.
    Galli M, Finazzi G, Barbui T. Thrombocytopenia in the antiphospholipid syndrome: pathophysiology, clinical relevance and treatment. Ann Med Interne. 1996;47:24–7.Google Scholar
  15. 15.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.CrossRefGoogle Scholar
  16. 16.
    Royal College of Obstetricians and Gynaecologists. Guidelines. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Guidelines No 37a, London: RCOG; 2009.Google Scholar
  17. 17.
    Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006;54:899–907.CrossRefGoogle Scholar
  18. 18.
    Silva CA, Hilario MO, Febronio MV, Oliveira SK, Almeida RG, Fonseca AR, et al. Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian Multicenter Cohort Study. J Rheumatol. 2008;35:1414–8.PubMedGoogle Scholar
  19. 19.
    Litttleton N. Thrombocytopenia in HIV. CME. 2007;25:272–5.Google Scholar
  20. 20.
    Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357:580–7.CrossRefGoogle Scholar
  21. 21.
    Greinacher A. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373:252–61.CrossRefGoogle Scholar
  22. 22.
    Ciurzynski M, Jankowski K, Pietrzak B, Mazanowska N, Rzewuska E, Kowalik R, et al. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. Med Sci Monit. 2011;17:56–9.CrossRefGoogle Scholar
  23. 23.
    Greinacher A, Eckhardt T, Mussmann J, Mueller-Eckhardt C. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Thromb Res. 1993;71:123–6.CrossRefGoogle Scholar
  24. 24.
    Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121:38–47.CrossRefGoogle Scholar
  25. 25.
    George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927–35.CrossRefGoogle Scholar
  26. 26.
    Esplin MS, Branch DW. Diagnosis and management of thrombotic microangiopathies during pregnancy. Clin Obstet Gynecol. 1999;42:360–8.CrossRefGoogle Scholar
  27. 27.
    Silver RM, Major H. Maternal coagulation disorders and postpartum hemorrhage. Clin Obstet Gynecol. 2010;53:252–64.CrossRefGoogle Scholar
  28. 28.
    Thachil J. Disseminated intravascular coagulation-new pathophysiological concepts and impact on management. Expert Rev Hematol. 2016;9:803–14.CrossRefGoogle Scholar
  29. 29.
    Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009;23:167.CrossRefGoogle Scholar
  30. 30.
    Montagnana M, Franchi M, Danese E, Gotsch F, Guidi GC. Disseminated intravascular coagulation in obstetric and gynecologic disorders. Semin Thromb Hemost. 2010;36:404–18.CrossRefGoogle Scholar
  31. 31.
    Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric haemorrhage. Int J Obstet Anesth. 2007;16:40–9.CrossRefGoogle Scholar
  32. 32.
    Maclean A, Almeida Z, Lopez P. Complications of acute fatty liver of pregnancy treated with activated protein C. Arch Gynecol Obstet. 2005;273:119–21.CrossRefGoogle Scholar
  33. 33.
    Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, Keeling DM, Liesner R, Brown SA, Hay CR, UK Haemophilia Centre Doctor’s Organisation. Acquired haemophilia a in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctor’s Organisation. Blood. 2007;109:1870–7.CrossRefGoogle Scholar
  34. 34.
    Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol. 2001;5:389–404.CrossRefGoogle Scholar
  35. 35.
    Peyvandi F, Bidlingmaier C, Garagiola I. Management of pregnancy and delivery in women with inherited bleeding disorders. Semin Fetal Neonatal Med. 2011;16:311–7.CrossRefGoogle Scholar
  36. 36.
    D’Andrea G, Chetta M, Margaglione M. Inherited platelet disorders: thrombocytopenias and thrombocytopathies. Blood Transfus. 2009;7:278–92.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Ganchev RV, Ludlam CA. Acquired and congenital hemostatic disorders in pregnancy and the puerperium. In: Arulkumaran S, Karoshi M, Keigh L, Lalonde A, B-Lynch C, editors. A comprehensive textbook of postpartum hemorrhage: an essential clinical reference for effective management. 2nd ed. London: Sapiens Publications; 2012. p. 199–217.Google Scholar
  38. 38.
    Fiore M, Nurden AT, Nurden P, Seligsohn U. Clinical utility gene card for: Glanzmann thrombasthenia. Eur J Hum Genet. 2012;20:1102.CrossRefGoogle Scholar
  39. 39.
    Nurden AT, Pillois X, Wilcox DA. Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost. 2013;39:642–55.CrossRefGoogle Scholar
  40. 40.
    Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246–53.CrossRefGoogle Scholar
  41. 41.
    Choi S, Brull R. Neuraxial techniques in obstetric and nonobstetric patients with common bleeding diatheses. Anesth Analg. 2009;109:648–60.CrossRefGoogle Scholar
  42. 42.
    Federici AB. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO.WILL study. Haemophilia. 2007;13:15–24.CrossRefGoogle Scholar
  43. 43.
    Butwick AJ, Carvalho B. Neuraxial anesthesia for cesarean delivery in a parturient with type 1 von Willebrand disease and scoliosis. J Clin Anesth. 2007;19:230–3.CrossRefGoogle Scholar
  44. 44.
    Lee CA, Chi C, Pavord SR, Bolton-Maggs PH, Pollard D, Hinchcliffe-Wood A, Kadir RA, UK Haemophilia Centre Doctors’ Organization. The obstetric and gynaecological management of women with inherited bleeding disorders–review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization. Haemophilia. 2006;12:301–36.CrossRefGoogle Scholar
  45. 45.
    Kadir R, Chi C, Bolton-Maggs P. Pregnancy and rare bleeding disorders. Haemophilia. 2009;15:990–1005.CrossRefGoogle Scholar
  46. 46.
    Eskandari N, Feldman N, Greenspoon JS. Factor VII deficiency in pregnancy treated with recombinant factor VIIa. Obstet Gynecol. 2002;99:935–7.PubMedGoogle Scholar
  47. 47.
    Singh A, Harnett MJ, Connors JM, Camann WR. Factor XI deficiency and obstetrical anesthesia. Anesth Analg. 2009;108:1882–5.CrossRefGoogle Scholar
  48. 48.
    Bhoi D, Sreekumar EJ, Anand RK, Baidya DK, Chhabra A. Anaesthesia management of caesarean section in a patient with severe factor XI deficiency. J Obstet Anaesth Crit Care. 2013;3:37–9.CrossRefGoogle Scholar
  49. 49.
    Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv. 2007;62:255–60.CrossRefGoogle Scholar
  50. 50.
    Katz D, Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth. 2015;15:ii75–88.CrossRefGoogle Scholar
  51. 51.
    Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK. Executive summary: regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35:102–5.CrossRefGoogle Scholar
  52. 52.
    Gogarten W, Vandermeulen E, Van Aken H, Kozek S, Llau JV, Samama CM. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol. 2010;27:999–1015.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Semra Karaman
    • 1
  • Zeynep Cagiran
    • 1
  1. 1.Ege University, School of MedicineIzmirTurkey

Personalised recommendations